文献速递造血干细胞移植与细胞治疗

恒定自然杀伤T细胞通过扩增供者调节性T细胞改善小鼠慢性移植物抗宿主病

Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.
PubMed 文献 · Blood · 2017-04-17

该研究在小鼠慢性移植物抗宿主病(cGVHD)模型中发现恒定自然杀伤T细胞(iNKT)显著减少,低剂量输注iNKT细胞(包括第三方iNKT)可预防并逆转已建立的cGVHD,其作用依赖调节性T细胞(Treg)扩增、IL-4产生及生发中心迁移,α-半乳糖神经酰胺体内刺激iNKT同样有效。

要点

  • cGVHD小鼠模型中iNKT细胞显著减少。
  • 低剂量iNKT细胞输注可预防并逆转已建立的cGVHD,第三方iNKT同样有效。
  • iNKT疗效依赖Treg,Treg清除可完全消除其治疗作用。

核心结论

  • 本研究证明cGVHD小鼠存在iNKT细胞缺陷,iNKT细胞在调控cGVHD发病机制中起关键作用,并可能成为cGVHD患者潜在的预防和治疗选择。

研究设计与样本

  • 研究采用可再现cGVHD患者自身免疫和器官纤维化部分特征的小鼠cGVHD模型。

主要发现

  • 在cGVHD小鼠模型中iNKT细胞显著减少。
  • 低剂量iNKT细胞输注有效预防并逆转已建立的cGVHD,第三方iNKT细胞同样有效。
  • iNKT细胞通过减少生发中心反应抑制自身免疫反应,伴随总Treg和滤泡调节性T细胞(Tfr)增加,并控制致病性抗体产生。
  • 输注iNKT细胞期间清除Treg可完全消除iNKT治疗cGVHD的疗效。
  • iNKT细胞产生白细胞介素4及生发中心迁移对逆转cGVHD至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic graft-versus-host-disease (cGVHD) can cause multiorgan system disease, typically with autoimmune-like features, resulting in high mortality and morbidity caused by treatment limitations. Invariant natural killer T cells (iNKTs), a small population characterized by expression of a semi-invariant T-cell receptor, rapidly produce copious amounts of diverse cytokines on activation that exert potent immune regulatory function. Here, we show that iNKTs are significantly reduced in a cGVHD murine model that recapitulates several aspects of autoimmunity and organ fibrosis observed in patients with cGVHD. Low iNKT infused doses effectively prevented and, importantly, reversed established cGVHD, as did third-party iNKTs. iNKTs suppressed the autoimmune response by reducing the germinal center (GC) reaction, which was associated with an increase in total Tregs and follicular Tregs (Tfr) that control the GC reaction, along with pathogenic antibody production. Treg depletion during iNKT infusions completely abolished iNKT efficacy in treating cGVHD. iNKT cell interleukin 4 production and GC migration were critical to cGVHD reversal. In vivo stimulation of iNKT cells by α-galactosyl-ceramide was effective in both preventing and treating cGVHD. Together, this study demonstrates iNKT deficiency in cGVHD mice and highlights the key role of iNKTs in regulating cGVHD pathogenesis and as a potentially novel prophylactic and therapeutic option for patients with cGVHD.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Du J, Paz K, Thangavelu G, et al. Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells. Blood. 2017. PMID: 28416503. doi:10.1182/blood-2016-11-752444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。